28例新生血管性青光眼治疗期疗效分析

Assessment of Therapeutic Effects of Neovascular Glaucoma in Treatment Period of 28 Cases

目的 回顾性分析 2 8例新生血管性青光眼的病因及疗效。方法 分析患眼原发病的比例 ,患眼临床症状及体征的发生率 ;总结湖南房水引流物置入术疗效。结果 临床表现主要为眼压升高 ,眼红 ,眼痛 ,虹膜及房角新生血管生成。行置入术的2 3眼平均眼压下降 19 13mmHg ,早期成功率为 87% ,术后浅前房及脉络膜脱离发生率分别为 47 8% ,3 9 1%。结论 新生血管性青光眼多继发于眼部缺血性疾病。在以预防为主的前提下 ,治疗应将去除缺血病变与降眼压并重。

To summarize the etiological factor and to assess the therapeutic effect for neovascular glaucoma(NVG).Methods A retrospective study of 28 cases (29 eyes) with NVG was performed. The mean age, proportion of sex and primary ocular disease, incidence of symptom, sign and postoperative complication were analyzed. Results 78 6% of the patients were over 40 years old. 62% of the patients were secondary to the ocular ischemic disease such as central retina vein occlusion and proliferative diabetic retinopathy. The clinical characters included intraocular pressure (IOP) increasing, pain, mixed conjunctival congestion and rubeosis iridis. The mean IOP reduction was 19.5 mmHg in 29 eyes after antiglaucomatous drags treatment and 19.13mmHg in 23 eyes after Hunan aqueous humor drainage (HAD) implantation. The common postoperative complications were flat anterior chamber and choroidal detachment. The success rate of HAD implantation was 87%.Conclusions NVG was commonly secondary to ocular ischemic disease. Although prevention was the principal, reducing IOP and ameliorating ischemic situation were as the same important.